Free Trial
NASDAQ:BBLGW

Bone Biologics (BBLGW) Stock Price, News & Analysis

Bone Biologics logo
$13.50 -3.40 (-20.12%)
As of 05/29/2025

About Bone Biologics Stock (NASDAQ:BBLGW)

Key Stats

Today's Range
$13.50
$13.50
50-Day Range
$13.50
$20.20
52-Week Range
$3.00
$95.04
Volume
200 shs
Average Volume
2,005 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Receive BBLGW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter.

BBLGW Stock News Headlines

BBLG Entering Critical Stage in Good Shape
BBLG in Good Shape as Testing Continues
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Tellgen Corporation (300642.SZ)
BBLG: Controls Costs and Advances Trials
Bone Biologics Corp Warrants (BBLGW)
See More Headlines

BBLGW Stock Analysis - Frequently Asked Questions

Bone Biologics' stock was trading at $40.00 at the beginning of 2025. Since then, BBLGW stock has decreased by 66.3% and is now trading at $13.50.
View the best growth stocks for 2025 here
.

Shares of Bone Biologics reverse split on Wednesday, June 7th 2023. The 1-30 reverse split was announced on Wednesday, June 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of BBLGW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBLGW
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:BBLGW) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners